Reagents for better science

Help & Info

Technology

We specialize in the production of high quality antibodies at industry-leading speeds.  Our HTPTM platform allows for product delivery in just two months, saving our customers time and money.  We utilize a genetically engineered mouse, parallel automated processes and proprietary technology to consistently outperform the market.
 

Please contact us or request a quote here to begin your project.

Abpro's HTPTM Platform

  • High speed
  • High affinity
  • Broad epitope diversity
  • Proven track record
  • Ability to make antibodies to difficult targets

What is the HTPTM Platform?

The HTPTM Platform is Abpro’s proprietary high-speed murine hybridoma production platform. The HTPTM Platform generates hybridomas in 40 days and delivers monoclonal cell lines guaranteed to be specific to your antigen in 40-60 days.  The HTPTM Platform is also capable of generating antibodies to targets that are traditionally difficult such as anti-idiotype and high homology targets.

 

How Does the HTPTM Platform Work?

At the core of the HTPTM Platform is our proprietary mouse.  Abpro’s HTPTM mouse has a boosted immune system which displays a broader epitope spread than any other strain of mouse.  The HTPTM mouse, combined with our optimized protocols, experienced scientists, and state-of-the-art lab equipment, allows Abpro to make highly specific and functional antibodies in less than half the time of conventional methods.
 
 

How Was the HTPTM Platform Developed?

Abpro’s founders examined the research environment and identified a bottleneck caused by a lack of quality reagents, specifically antibodies.  Because the classic antibody production process relies heavily on the immune system of a mouse to develop B-cells specific to the antigen, they set out to engineer a mouse that would optimize the monoclonal antibody development process.  They were successful; we call their breakthrough the ‘HTPTM Mouse’.
 

What Types of Projects are Best for the HTPTM Platform?

We recommend the HTPTM Platform to develop anything from therapeutic candidates to reagent antibodies.   Any time a quality antibody needs to be made right the first time, use the HTPTM platform.  
 
At Abpro, our data shows that the HTPTM Platform generates superior antibodies to the following targets:
 
 
Looking for more information?  Check out our FAQ’s or Contact a member of our sales department.

©2012 Abpro